OBJECTIVE:To investigate the effects ofAlisma orientalis polysaccharides on the insulin resistance and lipid metabolism disorder in type 2 diabetes mellitus (T2DM) rats and its possible mechanism.METHODS:T2DM rat model was induced by high fat diet combined with intraperitoneal injection of streptozotocin (30 mg/kg).50 model rats were randomly divided into model group (normal saline),glibenclamide group (positive control,25 mg/kg) and A.orientalis polysaccharide high-dose,medium-dose and low-dose groups (400,200,100 mg/kg),with 10 rats in each group.Other 10 normal rats were included in normal control group (normal saline).All groups were given drugs ig,once a day,for consecutive 6 weeks.After 5 weeks of administration,the glucose tolerance test was conducted.Fasting blood glucose (FBG) levels were measured in rats 0,30,60,90,120 min after intraperitoneal injection of 2 g/kg Glucose solution,respectively.After 6 weeks of administration,serum levels of FINS and FBG were measured,and HOMA-IR and insulin sensitivity index (ISI) were calculated;serum levels of FFA,LDL-C,HDL-C,TG and TC were detected,and the levels of SOD,GSH-Px and MDA in liver tissue were detected.RESULTS:Compared with normal control group,FBG levels of rats in model group at 0-120 min were increased significantly in glucose tolerance test.After 6 weeks of administration,the serum levels of FINS,LDL-C and ISI,and the levels of SOD and GSH-Px in the liver tissue of the model group were decreased,and the differences were statistically significant (P＜0.05).Compared with model group,each index of other administration group were improved significantly (P＜0.05),except that HOMA-IR,the serum levels of LDL-C and HDL-C were not significantly improved in A.orientalis polysaccharide low-dose group (P＞0.05).CONCLUSIONS:A.orientalis polysaccharide can improve insulin resistance and lipid metabolism disorder in T2DM rats through antioxidant effect.%目的:考察泽泻多糖对2型糖尿病(T2DM)大鼠胰岛素抵抗及脂代谢紊乱的影响及可能机制.方法:采用高脂饮食饲养联合腹腔注射链脲佐菌素(30 mg/kg)法建立T2DM大鼠模型.将造模成功的50只大鼠随机分为模型组(生理盐水)、格列本脲组(阳性对照,25 mg/kg)和泽泻多糖高、中、低剂量组(400、200、100 mg/kg),每组10只;另选10只正常大鼠作为正常对照组(生理盐水).各组均灌胃给药,每天1次,连续6周.给药5周后进行糖耐量实验,分别检测腹腔注射2 g/kg葡萄糖溶液后0、30、60、90、120 min大鼠空腹血糖(FBG)水平.给药6周后,检测大鼠血清中空腹胰岛素(FINS)、FBG水平并计算胰岛素抵抗指数(HOMA-IR)和胰岛素敏感指数(ISI);检测大鼠血清中游离脂肪酸(FFA)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)、三酰甘油(TG)、总胆固醇(TC)水平和肝组织中超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GSH-Px)、丙二醛(MDA)水平.结果:与正常对照组比较,糖耐量实验中,模型组大鼠0～120 min的FBG水平均升高;给药6周后,模型组大鼠血清中FINS、LDL-C水平和ISI以及肝组织中SOD、GSH-Px水平均降低,差异均有统计学意义(P＜0.05).与模型组比较,除泽泻多糖低剂量组大鼠HOMA-IR和血清中LDL-C、HDL-C水平改善不显著外(P＞0.05),其余各给药组大鼠各指标均显著改善(P＜0.05).结论:泽泻多糖可能通过抗氧化作用来改善T2DM大鼠胰岛素抵抗及脂代谢紊乱.
展开▼
